ANAPTYSBIO, INC ANAB on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001370053
0001370053
EIN:
20-3828755
20-3828755
LEI:
(CF Office: 03 Life Sciences)
Business address:
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Phone: 858-362-6295
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Phone: 858-362-6295
Mailing address:
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Former names:
- ANAPTYSBIO INC - filings through 2019-06-12
- ANAPTYS BIOSCIENCES INC - filings through 2007-11-20
Filings:
551 EDGAR filings since July 6, 2006
551 EDGAR filings since July 6, 2006
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- March 7, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 27, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- February 19, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
Selected Filings
[+] 8-K (current reports)
- March 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- February 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- February 19, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- February 12, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- February 3, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 7.01 - Regulation FD Disclosure
- December 11, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 27, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 5, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 5, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 9, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 24, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 27, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- January 15, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- January 7, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- March 7, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 18, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 12 of 551 entries
Data source:
CIK0001370053.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
